6680.HK
300748.SHE
Chuangxin does resources like aluminum

Rare earth magnetic materials producer JL Mag Rare-Earth Co. Ltd. (6680.HK; 300748.SZ) disclosed on Wednesday it has obtained export permits covering the U.S., Europe and Southeast Asia after China imposed controls in April on the export of medium and heavy rare earths.

The announcement lifted JL Mag’s Shenzhen-listed A shares by 7.89% to 24.07 yuan and its Hong Kong-listed shares by 1.75% to HK$19.70 on Wednesday.

JL Mag said its exports totaled 312 million yuan ($43 million) in the first quarter, of which the U.S. accounted for 122 million, or 6.94% of its overall revenue. The company does not engage in military-related business.

According to Caixin, after China imposed export controls on seven categories of medium and heavy rare earth elements in April, the country’s exports of rare earth permanent magnet iron that month fell by half to 2,626.7 tons month-on-month, with the top five destinations as Germany, Vietnam, the U.S., Italy and South Korea. The European and U.S. auto and semiconductor industries have been significantly affected by the export controls.

This week, Chinese and U.S. officials agreed in London on a six-month resumption of rare earth exports in exchange for eased U.S. jet engine export restrictions to China. China’s Ministry of Commerce confirmed that it has approved some compliant applications and will continue to review more.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Illustration of Luckin and Costa coffee being tasted

Luckin Coffee eyes global leap as China’s Double 11 loses its luster

Luckin could be preparing a bid for Costa Coffee. What's driving this potential deal, and what are its chances for success? And this year's Double 11 festival looks like a dud, with most big e-commerce companies failing to publish any big numbers. What does the future hold for this fast-fading shopping fest?
So-Young runs cosmetic surgery clinics

Can So-Young find new youth in bricks and mortar?

The cosmetic surgery specialist’s top line is growing as it opens new ‘light medical aesthetic’ clinics, but its bottom line is sagging as its older platform business evaporates Key Takeaways:…
CSPC delivered lower nine-month revenues and profits

CSPC feels the pain from sweeping cuts in drug prices

The pharmaceutical giant is paying the price for its aggressively low bids in China’s centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway: The…